394 related articles for article (PubMed ID: 28503091)
1. Natural Compounds as Anticancer Agents Targeting DNA Topoisomerases.
Jain CK; Majumder HK; Roychoudhury S
Curr Genomics; 2017 Feb; 18(1):75-92. PubMed ID: 28503091
[TBL] [Abstract][Full Text] [Related]
2. Secondary metabolites as DNA topoisomerase inhibitors: A new era towards designing of anticancer drugs.
Baikar S; Malpathak N
Pharmacogn Rev; 2010 Jan; 4(7):12-26. PubMed ID: 22228937
[TBL] [Abstract][Full Text] [Related]
3. Exploring DNA topoisomerases as targets of novel therapeutic agents in the treatment of infectious diseases.
Tse-Dinh YC
Infect Disord Drug Targets; 2007 Mar; 7(1):3-9. PubMed ID: 17346206
[TBL] [Abstract][Full Text] [Related]
4. Multiple Topoisomerase I (TopoI), Topoisomerase II (TopoII) and Tyrosyl-DNA Phosphodiesterase (TDP) inhibitors in the development of anticancer drugs.
Baglini E; Salerno S; Barresi E; Robello M; Da Settimo F; Taliani S; Marini AM
Eur J Pharm Sci; 2021 Jan; 156():105594. PubMed ID: 33059042
[TBL] [Abstract][Full Text] [Related]
5. Natural Products as Anti-Cancerous Therapeutic Molecules Targeted towards Topoisomerases.
Singh S; Pandey VP; Yadav K; Yadav A; Dwivedi UN
Curr Protein Pept Sci; 2020; 21(11):1103-1142. PubMed ID: 32951576
[TBL] [Abstract][Full Text] [Related]
6. Recent advances in the development of dual topoisomerase I and II inhibitors as anticancer drugs.
Salerno S; Da Settimo F; Taliani S; Simorini F; La Motta C; Fornaciari G; Marini AM
Curr Med Chem; 2010; 17(35):4270-90. PubMed ID: 20939813
[TBL] [Abstract][Full Text] [Related]
7. Topoisomerases: Resistance versus Sensitivity, How Far We Can Go?
Bansal S; Bajaj P; Pandey S; Tandon V
Med Res Rev; 2017 Mar; 37(2):404-438. PubMed ID: 27687257
[TBL] [Abstract][Full Text] [Related]
8. Drugging topoisomerases: lessons and challenges.
Pommier Y
ACS Chem Biol; 2013 Jan; 8(1):82-95. PubMed ID: 23259582
[TBL] [Abstract][Full Text] [Related]
9. Topoisomerase II inhibitors design: Early studies and new perspectives.
Swedan HK; Kassab AE; Gedawy EM; Elmeligie SE
Bioorg Chem; 2023 Jul; 136():106548. PubMed ID: 37094479
[TBL] [Abstract][Full Text] [Related]
10. Topoisomerase Inhibitors and Targeted Delivery in Cancer Therapy.
You F; Gao C
Curr Top Med Chem; 2019; 19(9):713-729. PubMed ID: 30931860
[TBL] [Abstract][Full Text] [Related]
11. Topoisomerase as target for antibacterial and anticancer drug discovery.
Kathiravan MK; Khilare MM; Nikoomanesh K; Chothe AS; Jain KS
J Enzyme Inhib Med Chem; 2013 Jun; 28(3):419-35. PubMed ID: 22380774
[TBL] [Abstract][Full Text] [Related]
12. Topoisomerase II Poisons: Converting Essential Enzymes into Molecular Scissors.
Vann KR; Oviatt AA; Osheroff N
Biochemistry; 2021 Jun; 60(21):1630-1641. PubMed ID: 34008964
[TBL] [Abstract][Full Text] [Related]
13. Topoisomerases and cancer chemotherapy: recent advances and unanswered questions.
Bjornsti MA; Kaufmann SH
F1000Res; 2019; 8():. PubMed ID: 31602296
[TBL] [Abstract][Full Text] [Related]
14. DNA Topoisomerases as Targets for Antibacterial Agents.
Hiasa H
Methods Mol Biol; 2018; 1703():47-62. PubMed ID: 29177732
[TBL] [Abstract][Full Text] [Related]
15. DNA Topoisomerases.
Evans-Roberts K; Maxwell A
EcoSal Plus; 2009 Aug; 3(2):. PubMed ID: 26443761
[TBL] [Abstract][Full Text] [Related]
16. Recent advancements in the medicinal chemistry of bacterial type II topoisomerase inhibitors.
Jaswal S; Nehra B; Kumar S; Monga V
Bioorg Chem; 2020 Nov; 104():104266. PubMed ID: 33142421
[TBL] [Abstract][Full Text] [Related]
17. Recent advances in the development of catalytic inhibitors of human DNA topoisomerase IIα as novel anticancer agents.
Pogorelčnik B; Perdih A; Solmajer T
Curr Med Chem; 2013; 20(5):694-709. PubMed ID: 23210851
[TBL] [Abstract][Full Text] [Related]
18. Recent developments of DNA poisons--human DNA topoisomerase IIα inhibitors--as anticancer agents.
Pogorelčnik B; Perdih A; Solmajer T
Curr Pharm Des; 2013; 19(13):2474-88. PubMed ID: 23363399
[TBL] [Abstract][Full Text] [Related]
19. Discovery and Development of Topoisomerase Inhibitors as Anticancer Agents.
Kathiravan MK; Kale AN; Nilewar S
Mini Rev Med Chem; 2016; 16(15):1219-1229. PubMed ID: 27549098
[TBL] [Abstract][Full Text] [Related]
20. DNA topoisomerases and their poisoning by anticancer and antibacterial drugs.
Pommier Y; Leo E; Zhang H; Marchand C
Chem Biol; 2010 May; 17(5):421-33. PubMed ID: 20534341
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
